Novo Nordisk A/S Class B (0QIU) RNS Announcements

Add to Alert list
Date Time Source Announcement
25 Nov 2025 11:24 AM
GNW
Novo Nordisk phase 2 trial with amycretin rep...
24 Nov 2025 11:20 AM
GNW
Novo Nordisk A/S: Evoke phase 3 trials did no...
14 Nov 2025 02:21 PM
GNW
Resolutions from the Extraordinary General Me...
13 Nov 2025 10:38 PM
GNW
Novo Nordisk A/S: Candidate for the Board of ...
06 Nov 2025 06:00 PM
GNW
Novo Nordisk announces agreement with the U.S...
05 Nov 2025 09:30 PM
GNW
Novo Nordisk Wegovy® users achieved waist and...
05 Nov 2025 06:30 AM
GNW
Novo Nordisk's sales increased by 12% in Dani...
30 Oct 2025 09:49 AM
GNW
Novo Nordisk submits proposal to acquire Mets...
21 Oct 2025 01:02 PM
GNW
Notice convening an Extraordinary General Mee...
21 Oct 2025 12:56 PM
GNW
Novo Nordisk announces an Extraordinary Gener...
15 Oct 2025 01:30 PM
GNW
Novo Nordisk and Omeros announce asset purcha...
09 Oct 2025 11:00 AM
GNW
Novo Nordisk to acquire Akero Therapeutics an...
18 Sep 2025 09:45 AM
GNW
Novo Nordisk A/S: Ozempic® reduces the risk o...
17 Sep 2025 10:05 PM
GNW
Novo Nordisk’s oral semaglutide 25 mg (Wegovy...
16 Sep 2025 11:00 AM
GNW
Novo Nordisk presents phase 3 data for next-g...
15 Sep 2025 11:03 PM
GNW
People taking Novo Nordisk’s Wegovy® experien...
15 Sep 2025 01:00 PM
GNW
EU approval makes Novo Nordisk’s oral semaglu...
10 Sep 2025 06:00 AM
GNW
Novo Nordisk to streamline operations and rei...
05 Sep 2025 07:01 AM
GNW
Novo Nordisk to present new semaglutide data ...
31 Aug 2025 08:09 AM
GNW
Novo Nordisk’s Wegovy® cuts risk of heart att...
20 Aug 2025 02:30 PM
GNW
Novo Nordisk to present Wegovy® and Ozempic® ...
15 Aug 2025 10:23 PM
GNW
Novo Nordisk A/S: Wegovy® approved in the US ...
06 Aug 2025 06:30 AM
GNW
Novo Nordisk's sales increased by 16% in Dani...
29 Jul 2025 12:35 PM
GNW
Maziar Mike Doustdar appointed as president a...
29 Jul 2025 12:01 PM
GNW
Novo Nordisk lowers sales and operating profi...
25 Jul 2025 11:47 AM
GNW
European regulatory authority adopts positive...
23 Jun 2025 07:36 PM
GNW
Novo Nordisk A/S: Ozempic® receives EU recomm...
22 Jun 2025 08:35 PM
GNW
Novo Nordisk A/S: Mim8 prophylaxis treatment ...
22 Jun 2025 02:00 PM
GNW
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg d...
21 Jun 2025 12:38 AM
GNW
Novo Nordisk: Higher dose of Wegovy® provided...
21 Jun 2025 12:34 AM
GNW
Novo Nordisk’s subcutaneous and oral amycreti...
12 Jun 2025 06:06 PM
GNW
Novo Nordisk to advance subcutaneous and oral...
10 Jun 2025 01:00 PM
GNW
ADA 2025: Novo Nordisk highlights strong port...
16 May 2025 12:01 PM
GNW
Novo Nordisk A/S: Lars Fruergaard Jørgensen t...
14 May 2025 11:59 AM
GNW
Novo Nordisk A/S: Septerna and Novo Nordisk t...
12 May 2025 07:01 AM
GNW
Novo Nordisk A/S: Once-weekly Sogroya® (somap...
07 May 2025 06:30 AM
GNW
Novo Nordisk's sales increased by 19% in Dani...
03 Apr 2025 07:00 AM
GNW
Novo Nordisk announces changes in Executive M...
29 Mar 2025 06:33 PM
GNW
Novo Nordisk A/S: Rybelsus® (oral semaglutide...
29 Mar 2025 02:33 PM
GNW
Ozempic® (once-weekly semaglutide 1.0 mg) sho...
27 Mar 2025 03:16 PM
GNW
Resolutions from the Annual General Meeting o...
24 Mar 2025 10:01 AM
GNW
The United Laboratories and Novo Nordisk anno...
10 Mar 2025 10:23 AM
GNW
Novo Nordisk A/S: CagriSema demonstrates supe...
27 Feb 2025 02:03 PM
GNW
Novo Nordisk A/S: Notice for the Annual Gener...
07 Feb 2025 07:45 AM
GNW
Novo Nordisk A/S: Once-weekly Mim8 is well-to...
05 Feb 2025 12:36 PM
GNW
Novo Nordisk files annual report with the SEC
05 Feb 2025 06:30 AM
GNW
Novo Nordisk's sales increased by 25% in Dani...
24 Jan 2025 10:19 AM
GNW
Novo Nordisk successfully completes phase 1b/...
17 Jan 2025 12:11 PM
GNW
Novo Nordisk A/S: Semaglutide 7.2 mg s.c. ach...
08 Jan 2025 11:30 AM
GNW
Valo Health and Novo Nordisk expand collabora...
UK 100

Latest directors dealings